Latest Insider Transactions at Owens & Minor Inc (OMI)
This section provides a real-time view of insider transactions for Owens & Minor Inc (OMI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OWENS & MINOR INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OWENS & MINOR INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2025
|
Jennifer A Stone EVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,764
-4.97%
|
$34,584
$6.35 P/Share
|
|
May 19
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-1.49%
|
$12,376
$7.38 P/Share
|
|
May 15
2025
|
Robert J Henkel Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+27.19%
|
-
|
|
May 15
2025
|
Teresa L. Kline Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.82%
|
-
|
|
May 15
2025
|
Carissa Rollins Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.91%
|
-
|
|
May 15
2025
|
Mark A Beck Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+41.92%
|
-
|
|
May 15
2025
|
Rita Johnson Mills Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.82%
|
-
|
|
May 15
2025
|
Stephen W Klemash Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+32.87%
|
-
|
|
May 15
2025
|
Kenneth Gardner Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.49%
|
-
|
|
May 15
2025
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,533
-1.24%
|
$10,731
$7.0 P/Share
|
|
May 15
2025
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,208
-2.97%
|
$246,456
$7.0 P/Share
|
|
May 15
2025
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
4,336
-3.84%
|
$30,352
$7.0 P/Share
|
|
May 15
2025
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
13,394
-5.41%
|
$93,758
$7.0 P/Share
|
|
May 15
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-1.1%
|
$9,205
$7.0 P/Share
|
|
May 15
2025
|
Jonathan A Leon EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,641
-1.17%
|
$18,487
$7.0 P/Share
|
|
May 15
2025
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
19,081
-6.79%
|
$133,567
$7.0 P/Share
|
|
Apr 10
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.69%
|
$560,000
$7.19 P/Share
|
|
Apr 09
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
225,000
+1.92%
|
$1,575,000
$7.39 P/Share
|
|
Apr 08
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
105,000
+0.92%
|
$735,000
$7.96 P/Share
|
|
Apr 07
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
240,000
+2.11%
|
$1,680,000
$7.84 P/Share
|
|
Apr 04
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
128,356
+1.16%
|
$1,026,848
$8.14 P/Share
|
|
Apr 03
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
160,000
+1.46%
|
$1,280,000
$8.53 P/Share
|
|
Mar 20
2025
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,578
-1.6%
|
$45,780
$10.09 P/Share
|
|
Mar 20
2025
|
Jonathan A Leon EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,961
-0.86%
|
$19,610
$10.09 P/Share
|
|
Mar 20
2025
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
5,551
-2.19%
|
$55,510
$10.09 P/Share
|
|
Mar 20
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,734
-2.23%
|
$27,340
$10.09 P/Share
|
|
Mar 20
2025
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
1,977
-1.72%
|
$19,770
$10.09 P/Share
|
|
Mar 20
2025
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,715
-1.23%
|
$147,150
$10.09 P/Share
|
|
Mar 20
2025
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,059
-0.85%
|
$10,590
$10.09 P/Share
|
|
Mar 04
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
800,000
+7.0%
|
$7,200,000
$9.75 P/Share
|
|
Mar 03
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
BUY
Grant, award, or other acquisition
|
Direct |
69,743
+36.22%
|
-
|
|
Mar 03
2025
|
Michael Wayne Lowry SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
28,166
+18.45%
|
-
|
|
Mar 03
2025
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
BUY
Grant, award, or other acquisition
|
Direct |
123,391
+32.79%
|
-
|
|
Mar 03
2025
|
Jonathan A Leon EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
134,121
+31.95%
|
-
|
|
Mar 03
2025
|
Snehashish Sarkar |
BUY
Grant, award, or other acquisition
|
Direct |
59,013
+33.93%
|
-
|
|
Mar 03
2025
|
Edward A Pesicka President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
445,279
+27.07%
|
-
|
|
Mar 03
2025
|
Andrew G Long EVP, CEO P&HS |
BUY
Grant, award, or other acquisition
|
Direct |
134,121
+31.95%
|
-
|
|
Mar 03
2025
|
Jennifer A Stone EVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
59,013
+33.7%
|
-
|
|
Mar 03
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
354,901
+3.49%
|
$3,194,109
$9.19 P/Share
|
|
Feb 28
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
1,738,511
+15.51%
|
$15,646,599
$9.39 P/Share
|
|
Nov 21
2024
|
Jonathan A Leon EVP & CFO |
SELL
Open market or private sale
|
Direct |
5,282
-3.88%
|
$58,102
$11.82 P/Share
|
|
Nov 18
2024
|
Snehashish Sarkar |
SELL
Open market or private sale
|
Direct |
2,055
-3.55%
|
$24,660
$12.26 P/Share
|
|
Nov 15
2024
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-2.02%
|
$14,352
$12.27 P/Share
|
|
Sep 23
2024
|
Jonathan A Leon EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
42,933
+23.98%
|
-
|
|
Aug 22
2024
|
Jonathan A Leon EVP & CFO |
SELL
Open market or private sale
|
Direct |
7,500
-7.45%
|
$112,500
$15.83 P/Share
|
|
Aug 08
2024
|
Andrew G Long EVP, CEO P&HS |
SELL
Bona fide gift
|
Direct |
70,898
-31.88%
|
-
|
|
Jul 01
2024
|
Michael Wayne Lowry SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
19,202
+16.62%
|
-
|
|
Jul 01
2024
|
Jonathan A Leon EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,202
+16.02%
|
-
|
|
Jun 06
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Open market or private sale
|
Direct |
20,015
-3.5%
|
$340,255
$17.48 P/Share
|
|
Jun 05
2024
|
Mark A Beck Director |
SELL
Open market or private sale
|
Direct |
9,344
-45.58%
|
$158,848
$17.25 P/Share
|